Nanoimaging for protein misfolding and related diseases

Journal of Cellular Biochemistry

Volumn 99, Issue 1, 2006, Pages 52-70

  Lyubchenko, Yuri L ^a   Sherman, Simon ^a   Shlyakhtenko, Luda S ^a   Uversky, Vladimir N ^b,c,d  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c INSTITUTE FOR BIOLOGICAL INSTRUMENTATION   (Russian Federation)

^d Molecular Kinetics Inc   (United States)

Author keywords

Atomic force microscopy; Conformational disease; Force spectroscopy; Nanomedicine; Protein aggregation; Protein misfolding; Single molecule analyses

Indexed keywords

NANOPARTICLE; PROTEIN; AMYLOID;

CYTOTOXICITY; DEGENERATIVE DISEASE; HUMAN; IMMUNITY; IN VITRO STUDY; MOLECULAR IMAGING; NANOTECHNOLOGY; PATHOLOGICAL ANATOMY; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN CONFORMATION; PROTEIN FOLDING; PROTEIN MISFOLDING; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; REVIEW; STRESS; ANIMAL; CHEMICAL STRUCTURE; CHEMISTRY; METABOLISM; METHODOLOGY; PATHOPHYSIOLOGY; THREE DIMENSIONAL IMAGING;

AMYLOID; ANIMALS; HUMANS; IMAGING, THREE-DIMENSIONAL; MODELS, MOLECULAR; NANOTECHNOLOGY; NEURODEGENERATIVE DISEASES; PROTEIN FOLDING; PROTEINS;

EID: 33748067296     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.20989     Document Type: Review

References (102)

1. Allen MW, Urbauer RJ, Zaidi A, Williams TD, Urbauer JL, Johnson CK. 2004. Fluorescence labeling, purification, and immobilization of a double cysteine mutant calmodulin fusion protein for single-molecule experiments. Anal Biochem 325:273-284.
2. Balbach JJ, Petkova AT, Oyler NA, Antzutkin ON, Gordon DJ, Meredith SC, Tycko R. 2002. Supramolecular structure in full-length Alzheimer's beta-amyloid fibrils: Evidence for a parallel beta-sheet organization from solid-state nuclear magnetic resonance. Biophys J 83:1205-1216.
3. Baxa U, Cheng N, Winkler DC, Chiu TK, Davies DR, Sharma D, Inouye H, Kirschner DA, Wickner RB, Steven AC. 2005. Filaments of the Ure2p prion protein have a cross-beta core structure. J Struct Biol 150:170-179.
4. Bellotti V, Mangione P, Stoppini M. 1999. Biological activity and pathological implications of misfolded proteins. Cell Mol Life Sci 55:977-991.
5. Bhatia R, Lin H, Lal R. 2000. Fresh and globular amyloid beta protein (1-42) induces rapid cellular degeneration: Evidence for AbetaP channel-mediated cellular toxicity. Faseb J 14:1233-1243.
6. Chan JC, Oyler NA, Yau WM, Tycko R. 2005. Parallel beta-sheets and polar zippers in amyloid fibrils formed by residues 10-39 of the yeast prion protein Ure2p. Biochemistry 44:10669-10680.
7. Clausen-Schaumann H, Seitz M, Krautbauer R, Gaub HE. 2000. Force spectroscopy with single bio-molecules. Curr Opin Chem Biol 4:524-530.
8. Croixmarie V, Briki F, David G, Coic YM, Ovtracht L, Doucet J, Jamin N, Sanson A. 2005. A cylinder-shaped double ribbon structure formed by an amyloid hairpin peptide derived from the beta-sheet of murine PrP: An X-ray and molecular dynamics simulation study. J Struct Biol 150:284-299.
9. D'Ursi AM, Armenante MR, Guerrini R, Salvadori S, Sorrentino G, Picone D. 2004. Solution structure of amyloid beta-peptide (25-35) in different media. J Med Chem 47:4231-4238.
10. Dawson TM, Dawson VL. 2003. Molecular pathways of neurodegeneration in Parkinson's disease. Science 302:819-822.
11. Demidov VV. 2004. Nanobiosensors and molecular diagnostics: A promising partnership. Expert Rev Mol Diagn 4:267-268.
12. Dietz H, Rief M. 2004. Exploring the energy landscape of GFP by single-molecule mechanical experiments. Proc Natl Acad Sci USA 101:16192-16197.
13. Dietz H, Rief M. 2006. Protein structure by mechanical triangulation. Proc Natl Acad Sci USA 103:1244-1247.
14. Dobson CM. 1999. Protein misfolding, evolution and disease. Trends Biochem Sci 24:329-332.
15. Dobson CM. 2004a. Experimental investigation of protein folding and misfolding. Methods 34:4-14.
16. Dobson CM. 2004b. Principles of protein folding, misfolding and aggregation. Semin Cell Dev Biol 15:3-16.
17. Dobson CM. 2005. Structural biology: Prying into prions. Nature 435:747-749.
18. Dunker AK, Obradovic Z, Romero P, Garner EC, Brown CJ. 2000. Intrinsic protein disorder in complete genomes. Genome Inform Ser Workshop Genome Inform 11:161-171.
19. Dunker AK, Lawson JD, Brown CJ, Williams RM, Romero P, Oh JS, Oldfield CJ, Campen AM, Ratliff CM, Hipps KW, Ausio J, Nissen MS, Reeves R, Kang C, Kissinger CR, Bailey RW, Griswold MD, Chiu W, Garner EC, Obradovic Z. 2001. Intrinsically disordered protein. J Mol Graph Model 19:26-59.
20. Dunker AK, Brown CJ, Lawson JD, Iakoucheva LM, Obradovic Z. 2002a. Intrinsic disorder and protein function. Biochemistry 41:6573-6582.
21. Dunker AK, Brown CJ, Obradovic Z. 2002b. Identification and functions of usefully disordered proteins. Adv Protein Chem 62:25-49.
22. Dunker AK, Cortese MS, Romero P, Iakoucheva LM, Uversky VN. 2005. Flexible nets. The roles of intrinsic disorder in protein interaction networks. FEBS J 272:5129-5148.
23. Durell SR, Guy HR, Arispe N, Rojas E, Pollard HB. 1994. Theoretical models of the ion channel structure of amyloid beta-protein. Biophys J 67:2137-2145.
24. Dyson HJ, Wright PE. 2005. Intrinsically unstructured proteins and their functions. Nat Rev Mol Cell Biol 6:197-208.
25. Engel A, Müller DJ. 2000. Observing single biomolecules at work with the atomic force microscope. Nat Struct Biol 7:715-718.
26. Fink AL. 1998. Protein aggregation: Folding aggregates, inclusion bodies and amyloid. Fold Des 3:R9-R23.
27. Fink AL. 2005. Natively unfolded proteins. Curr Opin Struct Biol 15:35-41.
28. Flory P. 1953. "Principles of Polymer Chemistry." New York: Cornell University Press.
29. Fotiadis D, Scheuring S, Müller SA, Engel A, Müller DJ. 2002. Imaging and manipulation of biological structures with the AFM. Micron 33:385-397.
30. Fotiadis D, Liang Y, Filipek S, Saperstein DA, Engel A, Palczewski K. 2003. Atomic-force microscopy. Rhodopsin dimers in native disc membranes. Nature 421:127-128.
31. Fotiadis D, Liang Y, Filipek S, Saperstein DA, Engel A, Palczewski K. 2004a. The G protein-coupled receptor rhodopsin in the native membrane. FEBS Lett 564:281-288.
32. Fotiadis D, Qian P, Philippsen A, Bullough PA, Engel A, Hunter CN. 2004b. Structural analysis of the reaction center light-harvesting complex I photosynthetic core complex of rhodospirillum rubrum using atomic force microscopy. J Biol Chem 279:2063-2068.
33. Glabe CG. 2004. Conformation-dependent antibodies target diseases of protein misfolding. Trends Biochem Sci 29:542-547.
34. Glabe CC. 2005. Amyloid accumulation and pathogensis of Alzheimer's disease: Significance of monomeric, oligomeric and fibrillar Abeta. Subcell Biochem 38:167-177.
35. Golde TE. 2005. The Abeta hypothesis: Leading us to rationally-designed therapeutic strategies for the treatment or prevention of Alzheimer disease. Brain Pathol 15:84-87.
36. Gutsmann T, Fantner GE, Kindt JH, Venturoni M, Danielsen S, Hansma PK. 2004. Force spectroscopy of collagen fibers to investigate their mechanical properties and structural organization. Biophys J 86:3186-3193.
37. Haas E. 2005. The study of protein folding and dynamics by determination of intramolecular distance distributions and their fluctuations using ensemble and single-molecule FRET measurements. Chemphyschem 6:858-870.
38. Harms GS, Orr G, Montal M, Thrall BD, Colson SD, Lu HP. 2003. Probing conformational changes of gramicidin ion channels by single-molecule patch-clamp fluorescence microscopy. Biophys J 85:1826-1838.
39. Hartley DM, Walsh DM, Ye CP, Diehl T, Vasquez S, Vassilev PM, Teplow DB, Selkoe DJ. 1999. Protofibrillar intermediates of amyloid beta-protein induce acute electrophysiological changes and progressive neurotoxicity in cortical neurons. J Neurosci 19:8876-8884.
40. Iakoucheva LM, Brown CJ, Lawson JD, Obradovic Z, Dunker AK. 2002. Intrinsic disorder in cell-signaling and cancer-associated proteins. J Mol Biol 323:573-584.
41. Inouye H, Kirschner DA. 2005. Alzheimer's beta-amyloid: Insights into fibril formation and structure from Congo red binding. Subcell Biochem 38:203-224.
42. Jager M, Michalet X, Weiss S. 2005. Protein-protein interactions as a tool for site-specific labeling of proteins. Protein Sci 14:2059-2068.
43. Jeyashekar NS, Sadana A, Vo-Dinh T. 2005. Protein amyloidose misfolding: Mechanisms, detection, and pathological implications. Methods Mol Biol 300:417-435.
44. Kapanidis AN, Lee NK, Laurence TA, Doose S, Margeat E, Weiss S. 2004. Fluorescence-aided molecule sorting: Analysis of structure and interactions by alternating-laser excitation of single molecules. Proc Natl Acad Sci USA 101:8936-8941.
45. Karsai A, Nagy A, Kengyel A, Martonfalvi Z, Grama L, Penke B, Kellermayer MS. 2005. Effect of lysine-28 side-chain acetylation on the nanomechanical behavior of alzheimer amyloid beta 25-35 fibrils. J Chem Inf Model 45:1641-1646.
46. Kayed R, Head E, Thompson JL, McIntire TM, Milton SC, Cotman CW, Glabe CG. 2003. Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science 300:486-489.
47. Kayed R, Sokolov Y, Edmonds B, McIntire TM, Milton SC, Hall JE, Glabe CG. 2004. Permeabilization of lipid bilayers is a common conformation-dependent activity of soluble amyloid oligomers in protein misfolding diseases. J Biol Chem 279:46363-46366.
48. Kedrov A, Ziegler C, Janovjak H, Kuhlbrandt W, Muller DJ. 2004. Controlled unfolding and refolding of a single sodium-proton antiporter using atomic force microscopy. J Mol Biol 340:1143-1152.
49. Kellermayer MS, Grama L, Karsai A, Nagy A, Kahn A, Datki ZL, Penke B. 2005. Reversible mechanical unzipping of amyloid beta-fibrils. J Biol Chem 280:8464-8470.
50. Kelly JW. 1998. The alternative conformations of amyloidogenic proteins and their multi-step assembly pathways. Curr Opin Struct Biol 8:101-106.
51. Kransnoslobodtsev AV, Shlyakhtenko LS, Egor Ukraintsev, Zaikova TO, Keana JFW, Lyubchenko YL. 2005. Nanomedicine and protein misfolding diseases, nanomedicine: Nanotechnol Biol Med 1:300-305.
52. Kuzmenkina EV, Heyes CD, Nienhaus GU. 2005. Single-molecule Forster resonance energy transfer study of protein dynamics under denaturing conditions. Proc Natl Acad Sci USA 102:15471-15476.
53. Lashuel HA, Hartley D, Petre BM, Walz T, Lansbury PT, Jr. 2002a. Neurodegenerative disease: Amyloid pores from pathogenic mutations. Nature 418:291.
54. Lashuel HA, Petre BM, Wall J, Simon M, Nowak RJ, Walz T, Lansbury PT, Jr. 2002b. Alpha-synuclein, especially the Parkinson's disease-associated mutants, forms pore-like annular and tubular protofibrils. J Mol Biol 322:1089-1102.
55. Lashuel HA, Hartley DM, Petre BM, Wall JS, Simon MN, Walz T, Lansbury PT, Jr. 2003. Mixtures of wild-type and a pathogenic (E22G) form of Abeta40 in vitro accumulate protofibrils, including amyloid pores. J Mol Biol 332:795-808.
56. Lin H, Bhatia R, Lal R. 2001. Amyloid beta protein forms ion channels: Implications for Alzheimer's disease pathophysiology. Faseb J 15:2433-2444.
57. Lu Y, Weers B, Stellwagen NC. 2001. DNA persistence length revisited. Biopolymers 61:261-275.
58. Luhrs T, Ritter C, Adrian M, Riek-Loher D, Bohrmann B, Dobeli H, Schubert D, Riek R. 2005. 3D structure of Alzheimer's amyloid-beta(1-42) fibrils. Proc Natl Acad Sci USA 102:17342-17347.
59. Ma B, Nussinov R. 2002. Stabilities and conformations of Alzheimer's beta - amyloid peptide oligomers (Abeta 16-22, Abeta 16-35, and Abeta 10-35): Sequence effects. Proc Natl Acad Sci USA 99:14126-14131.
60. Makin OS, Serpell LC. 2005. Structures for amyloid fibrils. FEBS J 272:5950-5961.
61. McAllister C, Karymov MA, Kawano Y, Lushnikov AY, Mikheikin A, Uversky VN, Lyubchenko YL. 2005. Protein Interactions and Misfolding Analyzed by AFM Force Spectroscopy. J Mol Biol 354:1028-1042.
62. Muchowski PJ, Wacker JL. 2005. Modulation of neurodegeneration by molecular chaperones. Nat Rev Neurosci 6:11-22.
63. Mucke L, Masliah E, Yu GQ, Mallory M, Rockenstein EM, Tatsuno G, Hu K, Kholodenko D, Johnson-Wood K, McConlogue L. 2000. High-level neuronal expression of abeta 1-42 in wild-type human amyloid protein precursor transgenic mice: Synaptotoxicity without plaque formation. J Neurosci 20:4050-4058.
64. Nelson R, Sawaya MR, Balbirnie M, Madsen AO, Riekel C, Grothe R, Eisenberg D. 2005. Structure of the cross-beta spine of amyloid-like fibrils. Nature 435:773-778.
65. O'Nuallain B, Wetzel R. 2002. Conformational Abs recognizing a generic amyloid fibril epitope. Proc Natl Acad Sci USA 99:1485-1490.
66. Oldfield CJ, Cheng Y, Cortese MS, Brown CJ, Uversky VN, Dunker AK. 2005a. Comparing and combining predictors of mostly disordered proteins. Biochemistry 44:1989-2000.
67. Oldfield CJ, Cheng Y, Cortese MS, Romero P, Uversky VN, Dunker AK. 2005b. Coupled folding and binding with alpha-helix-forming molecular recognition elements. Biochemistry 44:12454-12470.
68. Perutz MF, Finch JT, Berriman J, Lesk A. 2002a. Amyloid fibers are water-filled nanotubes. Proc Natl Acad Sci USA 99:5591-5595.
69. Perutz MF, Pope BJ, Owen D, Wanker EE, Scherzinger E. 2002b. Aggregation of proteins with expanded glutamine and alanine repeats of the glutamine-rich and asparagine-rich domains of Sup35 and of the amyloid beta-peptide of amyloid plaques. Proc Natl Acad Sci USA 99:5596-5600.
70. Petkova AT, Ishii Y, Balbach JJ, Antzutkin ON, Leapman RD, Delaglio F, Tycko R. 2002. A structural model for Alzheimer's beta - amyloid fibrils based on experimental constraints from solid state NMR. Proc Natl Acad Sci USA 99:16742-16747.
71. Petkova AT, Buntkowsky G, Dyda F, Leapman RD, Yau WM, Tycko R. 2004. Solid state NMR reveals a pH-dependent antiparallel beta-sheet registry in fibrils formed by a beta-amyloid peptide. J Mol Biol 335:247-260.
72. Ptitsyn OB. 1995a. How the molten globule became. Trends Biochem Sci 20:376-379.
73. Ptitsyn OB. 1995b. Molten globule and protein folding. Adv Protein Chem 47:83-229.
74. Ptitsyn OB, Bychkova VE, Uversky VN. 1995. Kinetic and equilibrium folding intermediates. Philos Trans R Soc Lond B Biol Sci 348:35-41.
75. Quist A, Doudevski I, Lin H, Azimova R, Ng D, Frangione B, Kagan B, Ghiso J, Lal R. 2005. Amyloid ion channels: A common structural link for protein-misfolding disease. Proc Natl Acad Sci USA 102:10427-10432.
76. Recchia A, Debetto P, Negro A, Guidolin D, Skaper SD, Giusti P. 2004. Alpha-synuclein and Parkinson's disease. FASEB J 18:617-626.
77. Rhee SK, Quist AP, Lal R. 1998. Amyloid beta protein-(1-42) forms calcium-permeable, Zn2+-sensitive channel. J Biol Chem 273:13379-13382.
78. Rochet JC, Lansbury PT, Jr. 2000. Amyloid fibrillogenesis: Themes and variations. Curr Opin Struct Biol 10:60-68.
79. Rochet JC, Outeiro TF, Conway KA, Ding TT, Volles MJ, Lashuel HA, Bieganski RM, Lindquist SL, Lansbury PT. 2004. Interactions among alpha-synuclein, dopamine, and biomembranes: Some clues for understanding neurodegeneration in Parkinson's disease. J Mol Neurosci 23:23-34.
80. Ross CA, Poirier MA. 2004. Protein aggregation and neurodegenerative disease. Nat Med 10(Suppl):S10-S17.
81. Salvetat J-P, Briggs GAD, Bonard J-M, Bacsa RR, Kulik AJ, Stoekli T, Burnham NA, Forró L. 1999. Elastic and shear moduli of single-walled carbon nanotube ropes. Phys Rev Let 82:944-947.
82. Schuler B, Lipman EA, Eaton WA. 2002. Probing the free-energy surface for protein folding with single-molecule fluorescence spectroscopy. Nature 419:743-747.
83. Segel DJ, Eliezer D, Uversky V, Fink AL, Hodgson KO, Doniach S. 1999. Transient dimer in the refolding kinetics of cytochrome c characterized by small-angle X-ray scattering. Biochemistry 38:15352-15359.
84. Selkoe DJ. 1997. Alzheimer's disease: Genotypes, phenotypes, and treatments. Science 275:630-631.
85. Serpell LC. 2000. Alzheimer's amyloid fibrils: Structure and assembly. Biochim Biophys Acta 1502:16-30.
86. Smith DP, Jones S, Serpell LC, Sunde M, Radford SE. 2003. A systematic investigation into the effect of protein destabilisation on beta 2-microglobulin amyloid formation. J Mol Biol 330:943-954.
87. Stasiak A. 1992. Three-stranded DNA structure; is this the secret of DNA homologous recognition? Mol Microbiol 6:3267-3276.
88. Stromer T, Serpell LC. 2005. Structure and morphology of the Alzheimer's amyloid fibril. Microsc Res Tech 67:210-217.
89. Tompa P. 2002. Intrinsically unstructured proteins. Trends Biochem Sci 27:527-533.
90. Tycko R. 2003. Insights into the amyloid folding problem from solid-state NMR. Biochemistry 42:3151-3159.
91. Tycko R. 2004. Progress towards a molecular-level structural understanding of amyloid fibrils. Curr Opin Struct Biol 14:96-103.
92. Urbanc B, Cruz L, Le R, Sanders J, Ashe KH, Duff K, Stanley HE, Irizarry MC, Hyman BT. 2002. Neurotoxic effects of thioflavin S-positive amyloid deposits in transgenic mice and Alzheimer's disease. Proc Natl Acad Sci USA 99:13990-13995.
93. Uversky VN. 2002a. Natively unfolded proteins: A point where biology waits for physics. Protein Sci 11:739-756.
94. Uversky VN. 2002b. What does it mean to be natively unfolded? Eur J Biochem 269:2-12.
95. Uversky VN. 2003. A protein-chameleon: Conformational plasticity of alpha-synuclein, a disordered protein involved in neurodegenerative disorders. J Biomol Struct Dyn 21:211-234.
96. Uversky VN, Fink AL. 2004. Conformational constraints for amyloid fibrillation: The importance of being unfolded. Biochim Biophys Acta 1698:131-153.
97. Uversky VN, Gillespie JR, Fink AL. 2000. Why are "natively unfolded" proteins unstructured under physiologic conditions? Proteins 41:415-427.
98. Uversky VN, Oldfield CJ, Dunker AK. 2005. Showing your ID: Intrinsic disorder as an ID for recognition, regulation and cell signaling. J Mol Recognit 18:343-384.
99. Veerhuis R, Boshuizen RS, Familian A. 2005. Amyloid associated proteins in Alzheimer's and prion disease. Curr Drug Targets CNS Neurol Disord 4:235-248.
100. Ward JJ, Sodhi JS, McGuffin LJ, Buxton BF, Jones DT. 2004. Prediction and functional analysis of native disorder in proteins from the three kingdoms of life. J Mol Biol 337:635-645.
101. Wright PE, Dyson HJ. 1999. Intrinsically unstructured proteins: Re-assessing the protein structure-function paradigm. J Mol Biol 293:321-331.
102. Xie Z, Srividya N, Sosnick TR, Pan T, Scherer NF. 2004. Single-molecule studies highlight conformational heterogeneity in the early folding steps of a large ribozyme. Proc Natl Acad Sci USA 101:534-539.